Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abbott™ Biosite™ Triage™ Drugs of Abuse Panel

Catalog No. 23034973
Change view
Click to view available options
Quantity:
25 Tests
Type:
Triage™ Drugs of Abuse Panel plus TCA
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity Type
23-034-973 25 Tests Triage™ Drugs of Abuse Panel plus TCA
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 23-034-973 Supplier Abbott™ Supplier No. 92000

Immunoassay for the qualitative determination of the presence of parent compound and/or major metabolites of up to nine distinct drug classes in urine

  • Test results from a urine sample in about 10 minutes
  • CLIA Complexity: Moderate
  • A self-contained, disposable, credit card-sized test device
  • Easy-to-read results for up to nine drug classes
  • Tests include amphetamines/methamphetamines, barbiturates, benzodiazepines, cocaine, marijuana, methadone, opiates, PCP and tricyclic antidepressants
  • The presence of color in any drug detection zone indicates the presence of the drug at or above the threshold concentrations
  • Built-in positive and negative controls in every device validate results
  • Kit sizes available in 25 test configurations

Specifications

Clia Complexity Moderate
Sample Type Urine
Type Triage™ Drugs of Abuse Panel plus TCA
Includes Amphetamines, Methamphetamines, Barbiturates, Benzodiazepines, Cocaine, Marijuana, Methadone, Opiates, PCP, Propoxyphene and Tricyclic Antidepressants
Quantity 25 Tests
Test Time 10 min.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.